Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $130
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $215 to $130.
Last updated: 2026-11-19 08:16:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Twist Bioscience Corporation (TWST) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $116.27, with a market capitalization of $7.64B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $25.23 to $219.71. This page covers its latest market performance, valuation, price trends and company information.
$7.64B | |
$112.11 | |
$119.52 | |
$110.48 | |
$112.00 | |
1.78M | |
2.47M | |
-- | |
$219.71 | |
$25.23 | |
-- | |
2026-09-30 |
Twist Bioscience Corporation (TWST) last closed at $116.27 as of 2026-11-19 01:01:00, up 3.86% ($4.32) from the previous close of $112.00.
During the latest regular trading session, TWST traded between $110.48 and $119.52, with a volume of 1.78M shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Twist Bioscience Corporation (TWST) moved from $132.13 to $116.27, representing a decline of 12.00% ($15.86).
The stock traded between $93.68 and $151.50 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 2.77 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 46.8%
TWST is currently trading at $116.27, placing it 46.8% of the way from its 52-week low of $25.23 to its 52-week high of $219.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Twist Bioscience Corp provides customizable solutions across the biological continuum, helping customers read, write and innovate in biology. The core of its business is a proprietary platform that allows it to manufacture synthetic DNA by writing DNA on a silicon chip. The company operates as one reportable and operating segment, through which it develops, manufactures and sells DNA Synthesis and Protein Solutions and NGS Applications products and services. It has presence in Americas, EMEA, and APAC. Majority of revenue comes from Americas. Its products are Genes, Oligo Pools, NGS, Variant Libraries, Synthetic Controls, Antibody Discovery, and VDR Solutions.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 979 |
| CEO | Emily Marine Leproust |
| Founded | 2013 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Twist Bioscience Corporation and TWST stock.
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $215 to $130.
Analysts raised CrowdStrike and Jazz targets, while cutting targets for Cisco, Fermi, Twist Bioscience, Applied Materials, Firefly and Nebius.
Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $190 to $175.
TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $190 to $137.
Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $205 to $150.
Eligible investors can buy real shares of Twist Bioscience Corporation (TWST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TWST, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TWST shares and USD.
TWST Shares to USD
1.00 TWST shares = 116.268 USD
Calculations are estimates based on the latest available price and are for reference only.